Markets Gone Wild

Texas Instruments’ Q4 2024 Results: A Challenging Environment and the Struggling Embedded Processing Segment Texas Instruments (TI), a leading semiconductor company, reported its fourth-quarter 2024 financial results, revealing a challenging business environment and a significant drag from its Embedded Processing segment. The company’s earnings missed analysts’ expectations, causing its stock to take a hit in…

Class Action Lawsuit Filed Against FTAI Aviation Ltd. for Alleged Securities Law Violations New York, NY – Lowey Dannenberg P.C., a leading law firm specializing in consumer and investor advocacy, has announced the filing of a class action lawsuit against FTAI Aviation Ltd. (FTAI or the Company) for alleged violations of the federal securities laws….

Elon Musk’s Predicted “Bright” Future Amidst Tesla’s Backlash Elon Musk, the visionary entrepreneur and CEO of Tesla, SpaceX, and SolarCity, has faced a significant amount of criticism recently due to his involvement in President Trump’s administration. Musk served on the Strategic and Policy Forum, an advisory group that disbanded in August 2017 after several members…

Occidental Petroleum Corp (NYSE: OXY) Records Losses Despite Confidence from Warren Buffett Occidental Petroleum Corp (NYSE: OXY), a favorite of Warren Buffett’s Berkshire Hathaway (NYSE: BRK.A), continues to record losses even as the billionaire maintains confidence in the company. Despite Buffett’s belief in the long-term potential of Occidental Petroleum, the company has faced challenges in…

Recovering Losses from ASP Isotopes Inc. Investment Introduction Investing in the stock market can be a risky endeavor, with the potential for both high returns and devastating losses. If you find yourself in the unfortunate position of suffering a loss on your ASP Isotopes Inc. (NASDAQ:ASPI) investment, there may be a glimmer of hope for…

Gannett Prepays $57.5 Million on First Lien Term Loan Facility New York, NY – In a recent business development, Gannett Co. (Gannett, we, us, our, or the Company) announced the prepayment of approximately $57.5 million on its five-year first lien term loan facility (the “2029 Term Loan Facility”). This prepayment was made during the first…

Sonoma Pharmaceuticals’ Q3 Financial Results: A 14% Revenue Growth and Positive Cash Flow Sonoma Pharmaceuticals, a pioneering healthcare company specializing in stabilized hypochlorous acid (HOCl) products, recently unveiled its financial performance for the third quarter and nine months ended December 31, 2024. The company reported impressive growth, with a 14% increase in revenues compared to…